LPM682000012, a Synthetic Neuroactive Steroid That Ameliorates Epileptic Seizures by Downregulating the Serpina3n/NF-κB Signaling Pathway
Molecules · 2024
DOI: 10.3390/molecules29225286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Xiaofan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Pharmacology and Drug Evaluation, School of Pharmacy, Ministry of Education, Collaborative Innovation Center of Advanced …. Hauptthemen laut MEDLINE: Signal Transduction, NF-kappa B, Seizures, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Science and Technology Project of Yantai, Major Basic Research Special Projects of Shandong Provincial, China.
Abstract (Originalsprache)
Epilepsy is characterized by abnormal neuronal firing in the brain. Several therapeutic strategies exist for epilepsy; however, several patients remain poorly treated. Therefore, the development of effective treatments remains a high priority in the field. Neuroactive steroids can potentiate extra-synaptic and synaptic GABAA receptors, thereby providing therapeutic benefits relative to benzodiazepines. This research study investigated the therapeutic effectiveness and underlying mechanisms of LPM682000012, a new synthetic neuroactive steroid-positive allosteric modulator (PAM) of GABAA receptors employed for treating epilepsy. Acute and chronic rat epilepsy models were established to identify the anti-seizure potency of LPM682000012. The dose-dependent sedative effects of LPM682000012 and Ganaxolone in normal rats were evaluated, which revealed that they both dose-dependently alleviated acute epileptic seizure in the pentylenetetrazol (PTZ)-mediated seizure model. Furthermore, LPM682000012 indicated an enhanced safety profile than Ganaxolone. Moreover, LPM682000012 also indicated therapeutic effects in the kainic acid (KA)-induced chronic spontaneous seizure model. Morphologically, LPM682000012 decreased neuronal loss in the hippocampal CA1 and CA3 regions and increased dendritic spine density in the CA1 region. In addition, mechanical analyses, including transcriptomics, Western blot, and proteomics analyses, revealed that the Serpina3n/NF-κB signaling pathway was up-regulated in epileptic rat hippocampal tissue, and LPM682000012 treatment reversed these changes. In summary, this report demonstrated that the novel neurosteroid GABAA PAM LPM682000012 activated the synaptic and extra-synaptic GABAA receptors and alleviated KA-induced neuronal loss and synaptic remodeling, potentially by down-regulating the Serpina3n/NF-κB signaling pathways. The results provide evidence that LPM682000012 is a potential anti-seizure pharmacotherapy candidate for epilepsy and warrants further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Molecular Pharmacology and Drug Evaluation, School of Pharmacy, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Ya…
- R & D Center, Luye Pharma Group Ltd., Yantai 264003, China.
ORCID-Profile: Xiaohui Sun
Förderung
- Natural Science Foundation of Shandong Province
- Science and Technology Project of Yantai
- Major Basic Research Special Projects of Shandong Provincial, China
Zitieren
APA
Zhang, X., Ji, S., Yang, Y., Sun, X., Wang, H., Yang, Y., Deng, X., Wang, Y., Li, C., & Tian, J. (2024). LPM682000012, a Synthetic Neuroactive Steroid That Ameliorates Epileptic Seizures by Downregulating the Serpina3n/NF-κB Signaling Pathway. Molecules. https://doi.org/10.3390/molecules29225286
Vancouver
Zhang X, Ji S, Yang Y, Sun X, Wang H, Yang Y, et al. LPM682000012, a Synthetic Neuroactive Steroid That Ameliorates Epileptic Seizures by Downregulating the Serpina3n/NF-κB Signaling Pathway. Molecules. 2024. doi:10.3390/molecules29225286
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaofan and Ji, Shengmin and Yang, Yue and Sun, Xiaohui and Wang, Hui and Yang, Yifan and Deng, Xuan and Wang, Yunjie and Li, Chunmei and Tian, Jingwei},
title = {LPM682000012, a Synthetic Neuroactive Steroid That Ameliorates Epileptic Seizures by Downregulating the Serpina3n/NF-κB Signaling Pathway},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29225286}
}
EUVIMED